Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

24 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Dexedrine Articles

Shire’s new drugs offset slumping Adderall in 3rd quarter 2009

2 November 2009

Stock Commentary - New York week to May 26, 2008

2 June 2008

US FDA clears Auriga's Liquadd for ADHD

17 March 2008

GSK's update warnings on Dexedrine in response to FDA call

4 September 2006

Barr's generic Adderall cleared in USA

31 March 2003

Ranbaxy gets OK for generic Adderall

1 July 2002

Barr gets US OK for generic Adderall

18 February 2002

Barr to launch Dexedrine Spansule generic in Feb?

28 January 2002

Blow for Shire as Barr predicts early approval for generic Adderall

29 November 2001

Mallinckrodt and SB sign Dexedrine deal

7 July 1999

ADHD undertreated, not overtreated

12 March 1999

Showing 1-11 of 11 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Is the diabetes market facing a blockbuster-free future?
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Is the diabetes market facing a blockbuster-free future?
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS